AddLife AB (publ) (ADDLF) Research

AddLife AB (publ) is a prominent supplier of specialized equipment, medical devices, and reagents. The company primarily caters to healthcare systems, research organizations, and academic institutions, while also serving the food and pharmaceutical industries. Its operations are structured into two distinct segments: Labtech and Medtech. The Labtech segment delivers products, complete solutions, and services crucial for diagnostics, biomedical research, and laboratory work. This includes offerings across a broad spectrum such as haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, and immunology, alongside consumables and analytical instruments. Additionally, this division provides essential support, maintenance, advisory, and training services. Conversely, the Medtech segment offers medical devices designed for diverse applications, including surgery, respiratory support, intensive care, wound treatment, enteral nutrition, fall prevention, and welfare technology. This also extends to assistive devices for ear, nose, and throat care, as well as bathroom aids and equipment tailored for children with disabilities. With a rich history dating back to its founding in 1906, AddLife AB (publ) is headquartered in Stockholm, Sweden, and operates extensively across Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, other European countries, and on an international scale.

Open AddLife AB (publ) (ADDLF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.